Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $116.9700 (0.29%) ($116.4300 - $117.4000) on Fri. Nov. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 79 | Latest Price | $116.9700(0.29%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(44%) SPLV(35%) XLP(33%) VYM(31%) DIA(30%) | Factors Impacting ABBV price | ABBV will decline at least -0.7% in a week (0% probabilities). VIXM(-20%) UUP(-12%) IGOV(-5%) VXX(-1%) TLT(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | 1.3 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $116.4(0.49%) | 10 Day Moving Average | $116.53(0.38%) | 20 Day Moving Average | $113.08(3.44%) | To recent high | -3.2% | To recent low | 9.9% | Market Cap | $206.368b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |